BioSpace News Archive

The FDA announced it has granted its first emergency use authorization for COVID-19 vaccine.

FlowMetric Life Sciences announces that its Clinical Laboratory, which provides clinical immune-monitoring services, has been awarded accreditation by the College of American Pathologists (CAP) following an on-site inspection as part of the CAP’s Laboratory Improvement Program.

Subsalve USA and Nanotronics Health donate medical devices and provide on-site training across Rhode Island healthcare system in joint humanitarian effort

icotec ag, a leading medical device manufacturer of Carbon/PEEK implants, strategically corporates with G-21 to distribute their bone cements in conjunction with icotec’s VADER® Pedicle Screw System in the United States.

atai Life Sciences (“atai” or the “Company”), a global biotech company developing psychedelic and non-psychedelic compounds for various mental health indications, has announced the appointment of Greg Weaver as Chief Financ

As we put the series of calamities that was 2020 behind us, many will pop a bottle of Champagne in celebration.

Veracyte, Inc . (Nasdaq: VCYT) announced new preliminary performance data for its noninvasive nasal swab test for early lung cancer detection and its Percepta Genomic Atlas for informing treatment decisions at the time of diagnosis. Both tests are in development and scheduled to launch in

Shipping COVID-19 vaccines to provider organizations is an immense logistical challenge. Health systems and physician clinics face their own challenge of logistics with limited resources: Educating patients about authorized vaccines, persuading them to schedule two timely visits, and reminding them to show up both times to receive the required doses

Corvion – developer of fully implanted mechanical circulatory support devices – announced today that it has received Breakthrough Device Designation for its fully implanted Left Ventricular Assist Device (LVAD) from the FDA.

Children’s Minnesota is pleased to announce the promotion of James C. Burroughs II from senior director to vice president, chief equity and inclusion officer, effective Jan. 9, 2021.